• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Allegro
    / Trima

    Active Ingredient

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Nasal Spray

    15 ml

    not in the basket chart 26019 1641


    Adults and children over 12 years of age: Two sprays into each nostril once daily – preferably in the morning. The maximum daily dose is 4 sprays into each nostril.
    Children 4-12 years of age: One spray into each nostril once daily – preferably in the morning. The maximum daily dose is 2 sprays into each nostril.
    This medicine is not intended for infants and children under 4 years of age.


    Prophylaxis and treatment of seasonal allergic rhinitis including hayfever, perenial rhinitis.


    Known or suspected pregnancy, hypersensitivity to any of the components, undiagnosed abnormal genital bleeding.

    Special Precautions

    Patient response should be monitored clinically and by lung function tests. Not for relief of acute symptoms for which a fast and short acting bronchodilator is required. Treatment should not be stopped abruptly, should be administered with caution in patients with pulmonary tuberculosis, severe cardiovascular disease, untreated hypokalaemia or thyrotoxicosis.

    Side Effects

    Cardiac arrhythmias may occur in some patients. Reports of arthralgia, myalgia, muscle cramps, abdominal pain, nausea, vomiting and hypersensitivity reactions, oedema and angioedema.

    Drug interactions

    Phenytoin, barbiturates, carbamazepine, aminoglutethimide, rifampicin. Thiazide and loop diuretics, cardiac glycosides, acetazolamide. Oral hypoglycemics, insulin, antihypertensives, anabolic steroids, ophthalmic idoxuridine. NSAIDs, aspirin, other salicylates, coumarin anticoagulants, vaccines, estrogens.

    Trima Israel Pharmaceutical Products Maabarot Ltd. Israel